| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| LUCIER GREGORY T | Director | C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE | /s/ Jessica Nielsen Causey, Attorney-in-Fact for Gregory T. Lucier | 03 Mar 2026 | 0001251299 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XRAY | Common Stock | Purchase | $392,521 | +27,555 | $14.24 | 27,555 | 02 Mar 2026 | By a Trust | F1, F2 | |
| transaction | XRAY | Common Stock | Purchase | $314,858 | +22,445 | +81% | $14.03 | 50,000 | 03 Mar 2026 | By a Trust | F1, F3 |
| holding | XRAY | Common Stock | 24,901 | 02 Mar 2026 | By Family Partnership | ||||||
| holding | XRAY | Common Stock | 21,000 | 02 Mar 2026 | By Gregory Lucier IRA |
| Id | Content |
|---|---|
| F1 | By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
| F2 | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.22 to $14.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $13.975 to $14.115, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |